Commercial-stage biotech TG Therapeutics (NASDAQ: TGTX) was having a fine week on the stock exchange, thanks in no small part ...

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript May 2, 2024 TG Therapeutics, Inc. isn't one of the 30 ...

TG Therapeutics beat first quarter revenue expectations and raised the full-year revenue guidance by $40 million at the ...

TG Therapeutics (TGTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Alec ...

TG Therapeutics, Inc. (NASDAQ:TGTX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus statutory numbers for both ...

TDP's TG Bharat promises to stabilize essential commodities prices, create jobs, and ensure industrial progress if TDP wins.

TG Therapeutics Inc ( NASDAQ:TGTX) released its 8-K filing on May 1, 2024, detailing a significant revenue increase in Q1 ...

By Sabela Ojea Shares of TG Therapeutics on Wednesday jumped after the company reported first-quarter revenue in the first quarter. The stock was up 27% ...

BRIUMVI U.S. net revenue of $50.5 million, representing >25% quarter over quarter growthTotal revenue for Q1 2024 of $63.5 ...

TG Bharat, TDP candidate, vowed to create 20 lakh jobs, ensure comprehensive Kurnool city assembly constituency development, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

TG Therapeutics missed on the bottom line, but investors were more cheered by the top-line development. TG Therapeutics' nearly $50.5 million in first-quarter product revenue derived entirely from ...